CDIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CDIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Cardio Diagnostics Holdings's Average Total Inventories for the three months ended in Dec. 2024 was $0.00 Mil. Cardio Diagnostics Holdings's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.00 Mil.
The historical rank and industry rank for Cardio Diagnostics Holdings's Days Inventory or its related term are showing as below:
Cardio Diagnostics Holdings's Days Inventory stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cardio Diagnostics Holdings's Inventory-to-Revenue for the three months ended in Dec. 2024 was 0.00.
The historical data trend for Cardio Diagnostics Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardio Diagnostics Holdings Annual Data | |||||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | ||||||
Days Inventory | - | - | - | - | - |
Cardio Diagnostics Holdings Quarterly Data | ||||||||||||||||
Dec20 | Mar21 | Jun21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Days Inventory | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the Biotechnology subindustry, Cardio Diagnostics Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Cardio Diagnostics Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cardio Diagnostics Holdings's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cardio Diagnostics Holdings's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as
Days Inventory (A: Dec. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2023 ) | + | Total Inventories (A: Dec. 2024 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2024 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 0 | * | 365 |
= | 0 | / | 0 | * | 365 | ||||
= | N/A |
Cardio Diagnostics Holdings's Days Inventory for the quarter that ended in Dec. 2024 is calculated as:
Days Inventory (Q: Dec. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2024 ) | + | Total Inventories (Q: Dec. 2024 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2024 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 0 | * | 365 / 4 |
= | 0 | / | 0 | * | 365 / 4 | ||||
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardio Diagnostics Holdings (NAS:CDIO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cardio Diagnostics Holdings's Inventory Turnover for the three months ended in Dec. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cardio Diagnostics Holdings's Inventory to Revenue for the three months ended in Dec. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0 | / | 0.005 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Cardio Diagnostics Holdings's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert Philibert | director, 10 percent owner, officer: Chief Medical Officer | 400 N. ABERDEEN, SUITE 900, CHICAGO IL 60642 |
Timur Dogan | officer: Chief Technology Officer | 400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642 |
Meeshanthini Dogan | director, 10 percent owner, officer: Chief Executive Officer | 400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642 |
Warren Hosseinion | director | C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801 |
Elisa V Luqman | officer: Chief Financial Officer | 37 HARRISON DRIVE, NORTHPORT NY 11768 |
Khullani Abdullahi | officer: VP of Revenue and Strategy | 400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642 |
Brandon Sim | director | C/O APOLLO MEDICAL HOLDINGS, INC., 1668 S. GARFIELD AVENUE, 3RD FLOOR, ALHAMBRA CA 91801 |
James Intrater | director | C/O CARDIO DIAGNOSTICS HOLDINGS INC., 400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642 |
Oded Levy | director | C/O CARDIO DIAGNOSTICS HOLDINGS INC., 400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642 |
Stanley K. Lau | director | C/O CARDIO DIAGNOSTICS HOLDINGS INC., 400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642 |
Bd Holding, Inc. | 10 percent owner | 15 PROSPECT PLACE, IOWA CITY IA 52246 |
Jonathan Intrater | officer: CEO | 223 PALMER STREET, PALMER MA 01069 |
Allan Liu | director | 1600 PARKWOOD CIRCLE, STE 200, ATLANTA GA 30339-2119 |
Loren Mortman | director | 207 EAST 74TH STREET, APARTMENT 10F, NEW YORK NY 10021 |
Mana Capital Llc | 10 percent owner | 8 THE GREEN, SUITE A, DOVER DE 19901 |
From GuruFocus
By Business Wire • 06-27-2024
By Business Wire • 10-17-2023
By Business Wire • 04-09-2024
By Business Wire • 11-07-2023
By Business Wire • 12-06-2023
By Business Wire • 12-04-2023
By Business Wire • 03-14-2024
By Business Wire • 11-20-2023
By Business Wire • 06-10-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.